Covered recipient · General Payments record
JEFF T BROWN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2025
$733.38
- Reported across 36 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $298.92 | 17 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $128.71 | 7 |
| Novo Nordisk AS | $51.80 | 3 |
| Abbott Laboratories | $41.73 | 2 |
| Acerta Pharma LLC | $33.94 | 2 |
| PFIZER INC. | $27.70 | 2 |
| Exact Sciences Corporation | $15.04 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $21.43 | 02/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240901445 | CMS |
| Abbott Laboratories | $20.30 | 06/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1241004601 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.50 | 09/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206651514 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.44 | 10/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206205613 | CMS |
| Exact Sciences Corporation | $15.04 | 03/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235350987 | CMS |
| Lilly USA, LLC | $20.67 | 02/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186698249 | CMS |
| Lilly USA, LLC | $17.61 | 04/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186678445 | CMS |
| Lilly USA, LLC | $15.82 | 04/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186716041 | CMS |
| Lilly USA, LLC | $16.98 | 05/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186742795 | CMS |
| Lilly USA, LLC | $17.75 | 06/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186742797 | CMS |
| Lilly USA, LLC | $19.94 | 08/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186678447 | CMS |
| Lilly USA, LLC | $19.94 | 10/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186730959 | CMS |
| Novo Nordisk Inc | $17.99 | 03/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188873000 | CMS |
| Novo Nordisk Inc | $20.31 | 05/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188443467 | CMS |
| Novo Nordisk Inc | $13.50 | 07/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188982452 | CMS |
| PFIZER INC. | $14.04 | 02/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1231361625 | CMS |
| PFIZER INC. | $13.66 | 03/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1231481909 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.